Buprenorphine And Naloxone Tablet
Product Images NDC 0054-0189

5 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 0054-0189). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 01

Image 01
Label for Buprenorphine and Naloxone Sublingual Tablets, USP, 2 mg/0.5 mg strength, packaged as 30 tablets. The label includes dosage information, pharmacist dispensing instructions, and is distributed by Hikma Pharmaceuticals USA Inc. It features a barcode and safety warnings emphasizing to keep out of reach of children.*
FDA Label Image

Image 02

Image 02
Chemical structure of buprenorphine represented as a molecular diagram, including atom connectivity and stereochemistry, along with the notation for the hydrochloride (HCl) salt form.*
FDA Label Image

Image 03

Image 03
An instructional illustration showing the placement of a sublingual tablet under the tongue inside an open mouth. The hand is holding the tablet to be positioned beneath the tongue, emphasizing the sublingual route of administration.*
FDA Label Image

Image 04

Image 04
Chemical structure of buprenorphine hydrochloride dihydrate, depicting its molecular framework as shown in the label image for buprenorphine and naloxone tablets by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Image 05

Image 05
Label for Buprenorphine and Naloxone Sublingual Tablets, USP, strength 8 mg / 2 mg. The package contains 30 tablets. Label includes warnings for children requiring emergency medical care if taken accidentally. Distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. Storage instructions and pharmacist dispensing note are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.